Research programme: chronic obstructive pulmonary disease therapy - Celestar Lexico-Sciences
Alternative Names: Chronic obstructive pulmonary disease therapy research programme - Celestar Lexico-Sciences; COPD therapy research programme - Celestar Lexico-Sciences; Research programme: COPD therapy - Celestar Lexico-SciencesLatest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator Celestar Lexico-Sciences
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Chronic obstructive pulmonary disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Chronic-obstructive-pulmonary-disease in Japan
- 23 May 2005 Celestar Lexico-Sciences' COPD therapy research programme is available for partnering for target identification/validation (http://www.cl-sciences.co.jp)
- 15 Apr 2005 Preclinical trials in Chronic obstructive pulmonary disease in Japan (unspecified route)